APR-246—The Mutant TP53 Reactivator—Increases the Effectiveness of Berberine and Modified Berberines to Inhibit the Proliferation of Pancreatic Cancer Cells
McCubrey, James Andrew, & Abrams, Stephen L., & Steelman, Linda S.. (February 2022).
APR-246—The Mutant TP53 Reactivator—Increases the Effectiveness of Berberine and Modified Berberines to Inhibit the Proliferation of Pancreatic Cancer Cells.
,
(),
-
. Retrieved from
http://hdl.handle.net/10342/11719
McCubrey, James Andrew, and Abrams, Stephen L., and Steelman, Linda S..
"APR-246—The Mutant TP53 Reactivator—Increases the Effectiveness of Berberine and Modified Berberines to Inhibit the Proliferation of Pancreatic Cancer Cells". .
. (),
February 2022.
September 30, 2023.
http://hdl.handle.net/10342/11719.
Chicago:
McCubrey, James Andrew and Abrams, Stephen L. and Steelman, Linda S.,
"APR-246—The Mutant TP53 Reactivator—Increases the Effectiveness of Berberine and Modified Berberines to Inhibit the Proliferation of Pancreatic Cancer Cells," , no.
(February 2022),
http://hdl.handle.net/10342/11719 (accessed
September 30, 2023).
AMA:
McCubrey, James Andrew, Abrams, Stephen L., Steelman, Linda S..
APR-246—The Mutant TP53 Reactivator—Increases the Effectiveness of Berberine and Modified Berberines to Inhibit the Proliferation of Pancreatic Cancer Cells. .
February 2022;
():
.
http://hdl.handle.net/10342/11719. Accessed
September 30, 2023.
